Financials
- Fiscal year
- 2025
- Total assets
- €6,009
- Loss
- -€1,948
- Solvency
- 50.8%
CardiAC
ActiveSummary
CardiAC has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3,052 and a net result of -€1,948. Its solvency ranks better than 40% of 19338 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Overview
Activity
Specialist medical practice
NACE 86220
1 site
Size
€6,009total assets 2025
- Equity
- €3,052
- Loss
- -€1,948
Turnover not published (abridged schema)
Structure
Accounts 155 d early0 of 1 deed read
Why 92+ Sector Human health activities (NACE 86)+ Liquidity: current ratio 2.03, cash €4,565+ Size: total assets €6,009+ Figures for FY 2025 (filed 26-02-2026)Show the evidence
Checked score
Score 2025
92
/ 100
Excellent
Probability in this band: under 0.55%
Better than 33% of its sector peers (NACE 86, micro)
Performance against the sector, not lower risk
Financial strength
Average
Solvency
76
equity 50.8% of total assets
Liquidity
75
short-term debt 49.2% · cash 76.0%
Profitability
0
return on assets -32.4%
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
- Sector Human health activities (NACE 86) lowers the probability
- Liquidity: current ratio 2.03, cash €4,565 lowers the probability
- Size: total assets €6,009 lowers the probability for this profile
- Figures for FY 2025 (filed 26-02-2026) lowers the probability
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, micro). Better than this share of them on solvency 40%, liquidity 57%, profitability 1%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Young company
Founded in 2025, under 3 years in business. Failure risk is statistically highest between 2 and 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-02-2026, 155 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
155 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
- Annual accounts filedfiscal year 2025 · micro…
Key points
By topic
Timeline
- Events
- 1
- Since
- 2026
- 26-02-2026Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Specialist medical practiceNACE 86220
- Founded
- 25-09-2025
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.